Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$2,163,287
-23.34%
Shares
Shares Volume: 50,309 Shares
Average Share Price: $43
INSIDER
ZANTE GREG
Chief Financial Officer (Officer)
reported on Jan 6 2025
traded on Jan 3 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 165,259 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $4,597,603.67 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 23 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $3,899,126.49 |
| COMPANY PREVIOUS TRADES |